Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low OGDHL expression affects the prognosis and immune infiltration of kidney renal clear cell carcinoma. | Transl Cancer Res | 2023 | 38130311 | PubTator, text mining | PubMed |
| The role of RNA modification in urological cancers: mechanisms and clinical potential. | Discov Oncol | 2023 | 38117350 | PubTator, text mining | PubMed |
| Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis. | World J Surg Oncol | 2023 | 38114977 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate suppresses GLUT activity through PP2A and counteracts hyperglycemia in diabetic red blood cells. | Nat Commun | 2023 | 38097610 | PubTator, text mining | PubMed |
| Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes. | Nat Commun | 2023 | 38086799 | PubTator, text mining | PubMed |
| Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma. | Technol Cancer Res Treat | 2023 | 38083797 | PubTator, text mining | PubMed |
| Glutamine addiction and therapeutic strategies in pancreatic cancer. | World J Gastrointest Oncol | 2023 | 38077649 | PubTator, text mining | PubMed |
| Histone ubiquitination-related gene CUL4B promotes lung adenocarcinoma progression and cisplatin resistance. | Front Genet | 2023 | 38075690 | PubTator, text mining | PubMed |
| Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases. | eGastroenterology | 2023 | 38074919 | PubTator, text mining | PubMed |
| Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. | Signal Transduct Target Ther | 2023 | 38072908 | PubTator, text mining | PubMed |
| Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles. | Int J Mol Sci | 2023 | 38069306 | PubTator, text mining | PubMed |
| Phenotypic profiling of solute carriers characterizes serine transport in cancer. | Nat Metab | 2023 | 38066114 | PubTator, text mining | PubMed |
| LncRNA SLC1A5-AS/MZF1/ASCT2 Axis Contributes to Malignant Progression of Hepatocellular Carcinoma. | Discov Med | 2023 | 38058065 | PubTator, text mining | PubMed |
| Research progress in the role and mechanism of Leucine in regulating animal growth and development. | Front Physiol | 2023 | 38046946 | PubTator, text mining | PubMed |
| Membrane transporters in cell physiology, cancer metabolism and drug response. | Dis Model Mech | 2023 | 38037877 | PubTator, text mining | PubMed |
| Clinical practice in prostate PET imaging. | Ther Adv Med Oncol | 2023 | 38028142 | PubTator, text mining | PubMed |
| The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 38027094 | PubTator, text mining | PubMed |
| NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor. | Front Pharmacol | 2023 | 38027016 | PubTator, text mining | PubMed |
| Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle. | Exp Ther Med | 2023 | 38023359 | PubTator, text mining | PubMed |
| CD147: an integral and potential molecule to abrogate hallmarks of cancer. | Front Oncol | 2023 | 38023152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=19